Athenahealth – Post-sale Analysis & Q1 2022 Update

  • Credit
  • Healthcare
  • North America


Former executive director at Athenahealth Inc


  • Recent trends and developments in the EHR (electronic health record) and EMR (electronic medical record) industries
  • Ambulatory EMR offerings, data interoperability pain points and ability to improve technological integration, including athenaOne product and Insights Dashboard analysis
  • Contract dynamics and ability to defend ambulatory position against eClinicalWorks, Greenway Health and encroachment by larger players
  • Consolidation dynamics, including Oracle's (NYSE: ORCL) Cerner (NASDAQ: CERN) acquisition and Athenahealth's recent sale to PE
  • 2022 post-sale outlook, including growth expectations and strategic assessments


Gain access to Premium Content

Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.

    One week, unlimited access to over 35,000 transcripts
The information, material and content contained in this transcript (“Content”) is for information purposes only and does not constitute advice of any type or a trade recommendation and should not form the basis of any investment decision.This transcript has been edited by Third Bridge for ease of reading. Third Bridge Group Limited and its affiliates (together “Third Bridge”) make no representation and accept no liability for the Contentor for any errors, omissions or inaccuracies in respect of it. The views of the specialist expressed in the Content are those of the specialist and they are not endorsed by, nor do they represent the opinion of, Third Bridge. Third Bridge reserves all copyright, intellectual and other property rights in the Content. Any modification, reformatting, copying, displaying, distributing, transmitting, publishing, licensing, creating derivative works from, transferring or selling any Content is strictly prohibited